RAS Blockade in Advanced CKD

This chapter examines a meta-analysis on the efficacy of Renin Angiotensin System blockade in patients with advanced chronic kidney disease, showing a notable reduction in kidney failure events. It also discusses the complexities of treatment, including potassium management and the potential role of SGLT2 inhibitors.